{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:23:47Z","timestamp":1794313427526,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Multiple clinical prediction rules have been published to risk-stratify febrile infants \u226460\u2009days of age for serious bacterial infections (SBI), which is present in 8-13% of infants. We evaluate the cost-effectiveness of strategies to identify infants with SBI in the emergency department.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We developed a Markov decision model to estimate outcomes in well-appearing, febrile term infants, using the following strategies: Boston, Rochester, Philadelphia, Modified Philadelphia, Pediatric Emergency Care Applied Research Network (PECARN), Step-by-Step, Aronson, and clinical suspicion. Infants were categorized as low risk or not low risk using each strategy. Simulated cohorts were followed for 1 year from a healthcare perspective. Our primary model focused on bacteremia, with secondary models for urinary tract infection and bacterial meningitis. One-way, structural, and probabilistic sensitivity analyses were performed. The main outcomes were SBI correctly diagnosed and incremental cost per quality-adjusted life-year (QALY) gained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the bacteremia model, the PECARN strategy was the least expensive strategy ($3671, 0.779 QALYs). The Boston strategy was the most cost-effective strategy and cost $9799\/QALY gained. All other strategies were less effective and more costly. Despite low initial costs, clinical suspicion was among the most expensive and least effective strategies. Results were sensitive to the specificity of selected strategies. In probabilistic sensitivity analyses, the Boston strategy was most likely to be favored at a willingness-to-pay threshold of $100,000\/QALY. In the urinary tract infection model, PECARN was preferred compared to other strategies and the Boston strategy was preferred in the bacterial meningitis model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Boston clinical prediction rule offers an economically reasonable strategy compared to alternatives for identification of SBI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-03057-5","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T09:03:18Z","timestamp":1643878998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk-stratification in febrile infants 29 to 60\u2009days old: a cost-effectiveness analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Kathleen A.","family":"Noorbakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Ramgopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy S.","family":"Rixe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dunnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"3057_CR1","first-page":"1","volume":"372","author":"L McCaig","year":"2006","unstructured":"McCaig L, Nawar E. National hospital ambulatory medical care survey: 2004 emergency department summary. Adv Data. 2006;372:1\u201329.","journal-title":"Adv Data"},{"key":"3057_CR2","volume-title":"National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary","author":"R Niska","year":"2010","unstructured":"Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary, vol. 26. Hyattsville: National health statistics reports; 2010."},{"issue":"1","key":"3057_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1542\/peds.90.1.5","volume":"90","author":"D Nelson","year":"1992","unstructured":"Nelson D, Walsh K, Fleisher G. Spectrum and frequency of illness presenting to a pediatric emergency department. Pediatrics. 1992;90(1):5\u201310.","journal-title":"Pediatrics."},{"issue":"4","key":"3057_CR4","first-page":"775","volume":"135","author":"P Aronson","year":"2015","unstructured":"Aronson P, Thurm C, Alpern E, Alessandrini E, Williams D, Shah S, et al. Variation in Care of the Febrile Young Infant, 90 days in US pediatric emergency departments (pediatrics (2014) 134:4 (667-677)). Pediatrics. 2015;135(4):775.","journal-title":"Pediatrics."},{"issue":"6","key":"3057_CR5","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1542\/peds.2013-1759","volume":"132","author":"E Biondi","year":"2013","unstructured":"Biondi E, Evans R, Mischler M, Bendel-Stenzel M, Horstmann S, Lee V, et al. Epidemiology of bacteremia in febrile infants in the United States. Pediatrics. 2013;132(6):990\u20136.","journal-title":"Pediatrics."},{"issue":"2","key":"3057_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2017-2384","volume":"141","author":"AJ Blaschke","year":"2018","unstructured":"Blaschke AJ, Korgenski EK, Wilkes J, Presson AP, Thorell EA, Pavia AT, et al. Rhinovirus in febrile infants and risk of bacterial infection. Pediatrics. 2018;141(2):1\u20139.","journal-title":"Pediatrics."},{"key":"3057_CR7","doi-asserted-by":"crossref","unstructured":"Byington CL, Reynolds CC, Korgenski K, Sheng X, Valentine KJ, Nelson RE, et al. Costs and infant outcomes after implementation of a care process model for febrile infants. Pediatrics. 2012;130(1):e16\u201324.","DOI":"10.1542\/peds.2012-0127"},{"issue":"3","key":"3057_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1542\/peds.106.3.477","volume":"106","author":"G Klinger","year":"2000","unstructured":"Klinger G, Chin CN, Beyene J, Perlman M. Predicting the outcome of neonatal bacterial meningitis. Pediatrics. 2000;106(3):477\u201382.","journal-title":"Pediatrics."},{"issue":"7","key":"3057_CR9","first-page":"665","volume":"103","author":"S Mintegi","year":"2018","unstructured":"Mintegi S, Gomez B, Carro A, Diaz H, Benito J. Invasive bacterial infections in young afebrile infants with a history of fever. Arch Dis Child. 2018;103(7):665\u20139.","journal-title":"Arch Dis Child"},{"issue":"12","key":"3057_CR10","first-page":"1146","volume":"137","author":"C Deangelis","year":"1983","unstructured":"Deangelis C, Joffe A, Wilson M, Willis E. Iatrogenic risks and financial costs of hospitalizing febrile infants. Am J Dis Child. 1983;137(12):1146\u20139.","journal-title":"Am J Dis Child"},{"key":"3057_CR11","doi-asserted-by":"crossref","unstructured":"Gomez B, Mintegi S, Bressan S, Da Dalt L, Gervaix A, Lacroix L. Validation of the \u201cstep-by-step\u201d approach in the management of young febrile infants. Pediatrics. 2016;138(2):e20154381.","DOI":"10.1542\/peds.2015-4381"},{"key":"3057_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamapediatrics.2018.5501","volume":"173","author":"N Kuppermann","year":"2019","unstructured":"Kuppermann N, Dayan PS, Levine DA, Vitale M, Tzimenatos L, Tunik MG, et al. A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr. 2019;173:342\u201351.","journal-title":"JAMA Pediatr"},{"key":"3057_CR13","doi-asserted-by":"crossref","unstructured":"Aronson PL, Wang ME, Shapiro ED, Shah SS, DePorre AG, McCulloh RJ, et al. Risk stratification of febrile infants \u226460 days old without routine lumbar puncture. Pediatrics. 2018;142(6):e20181879.","DOI":"10.1542\/peds.2018-1879"},{"issue":"1","key":"3057_CR14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3604","volume":"144","author":"PL Aronson","year":"2019","unstructured":"Aronson PL, Shabanova V, Shapiro ED, Wang ME, Nigrovic LE, Pruitt CM, et al. A prediction model to identify febrile infants \u226460 days at low risk of invasive bacterial infection. Pediatrics. 2019;144(1):e20183604.","journal-title":"Pediatrics."},{"issue":"6","key":"3057_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0022-3476(85)80175-X","volume":"107","author":"R Dagan","year":"1985","unstructured":"Dagan R, Powell KR, Hall CB, Menegus MA. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. 1985;107(6):855\u201360.","journal-title":"J Pediatr"},{"issue":"1","key":"3057_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0022-3476(05)80591-8","volume":"120","author":"MN Baskin","year":"1992","unstructured":"Baskin MN, O\u2019Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr. 1992;120(1):22\u20137.","journal-title":"J Pediatr"},{"issue":"20","key":"3057_CR17","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJM199311113292001","volume":"329","author":"MD Baker","year":"1993","unstructured":"Baker MD, Bell L, Avner JR. Outpatient mannagmeent without antibiotics of fever in selected infants. N Engl J Med. 1993;329(20):1437\u201341.","journal-title":"N Engl J Med"},{"key":"3057_CR18","doi-asserted-by":"crossref","unstructured":"Nigrovic LE, Mahajan PV, Blumberg SM, Browne LR, Linakis JG, Ruddy RM, et al. The Yale observation scale score and the risk of serious bacterial infections in febrile infants. Pediatrics. 2017;140(1):e20170695.","DOI":"10.1542\/peds.2017-0695"},{"key":"3057_CR19","doi-asserted-by":"crossref","unstructured":"Garra G, Cunningham SJ, Crain EF. Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age.\u00a0Acad Emerg Med. 2005;12(10):921\u20135.","DOI":"10.1197\/j.aem.2005.06.006"},{"key":"3057_CR20","doi-asserted-by":"crossref","unstructured":"Jaskiewicz JA, McCarthy CA, Richardson AC, White KC, Fisher DJ, Powell KR, Dagan R, Febrile Infant Collaborative Study Groups. Febrile infants at low risk for serious bacterial infection\u2014an appraisal of the Rochester criteria and implications for management. Pediatrics. 1994;94(3):390\u20136.","DOI":"10.1542\/peds.94.3.390"},{"key":"3057_CR21","doi-asserted-by":"crossref","unstructured":"Baker MD, Bell LM. Unpredictability of serious bacterial illness in febrile infants from birth to 1 month of age.\u00a0Arch Pediatr Adolesc Med. 1999;153(5):508\u201311.","DOI":"10.1001\/archpedi.153.5.508"},{"key":"3057_CR22","doi-asserted-by":"crossref","unstructured":"Kaplan RL, Harper MB, Baskin MN, Macone AB, Mandl KD. Time to detection of positive cultures in 28-to 90-day-old febrile infants. Pediatrics. 2000;106(6):e74.","DOI":"10.1542\/peds.106.6.e74"},{"key":"3057_CR23","doi-asserted-by":"crossref","unstructured":"Velasco R, Gomez B, Benito J, Mintegi S. Accuracy of PECARN rule for predicting serious bacterial infection in infants with fever without a source.\u00a0Arch Dis Child. 2021;106(2):143\u20138.","DOI":"10.1136\/archdischild-2020-318882"},{"issue":"10","key":"3057_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0139140","volume":"10","author":"SL Hoshi","year":"2015","unstructured":"Hoshi SL, Kondo M, Okubo I. Economic evaluation of immunisation programme of 23-valent pneumococcal polysaccharide vaccine and the inclusion of 13-valent pneumococcal conjugate vaccine in the list for single-dose subsidy to the elderly in Japan. PLoS One. 2015;10(10):1\u201316.","journal-title":"PLoS One"},{"issue":"4","key":"3057_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3233\/JAD-170324","volume":"60","author":"RLH Handels","year":"2017","unstructured":"Handels RLH, Wimo A, Dodel R, Kramberger MG, Visser PJ, Molinuevo JL, et al. Cost-utility of using Alzheimer\u2019s disease biomarkers in cerebrospinal fluid to predict progression from mild cognitive impairment to dementia. J Alzheimers Dis. 2017;60(4):1477\u201387.","journal-title":"J Alzheimers Dis"},{"key":"3057_CR26","unstructured":"CPI Inflation Calculator [Internet]. CPI INflation Calculator. 2019. p. 1\u20132. Available from: https:\/\/data.bls.gov\/cgi-bin\/cpicalc.pl."},{"key":"3057_CR27","unstructured":"Clinical Laboratory Fee Schedule 2016 [Internet]. Centers for Medicare & Medicaid Services. 2019. Available from: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/index.html."},{"issue":"2","key":"3057_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/jech.56.2.85","volume":"56","author":"A Shiell","year":"2002","unstructured":"Shiell A, Donaldson C, Mitton C, Currie G. Health economic evaluation. J Epidemiol Community Health. 2002;56(2):85\u20138.","journal-title":"J Epidemiol Community Health"},{"issue":"8","key":"3057_CR29","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1542\/peds.89.6.1135","volume":"89","author":"T Lieu","year":"1992","unstructured":"Lieu T, Baskin M, Schwartz J, Fleischer G. Clinical and cost-effectiveness of outpatient strategies for managment of febrile infants. Pediatrics. 1992;89(8):1135\u201344.","journal-title":"Pediatrics."},{"issue":"1","key":"3057_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/INF.0b013e3182a72ee0","volume":"33","author":"MH Tsai","year":"2014","unstructured":"Tsai MH, Hsu JF, Chu SM, Lien R, Huang HR, Chiang MC, et al. Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J. 2014;33(1):7\u201313.","journal-title":"Pediatr Infect Dis J"},{"key":"3057_CR31","unstructured":"Hui C, Neto G, Tsertsvadze A, Yazdi F, Tricco A, Tsouros S, Skidmore B, \nDaniel R. Diagnosis and Management of Febrile Infants (0\u20133 months). Evidence \nReport\/Technology Assessment No. 205 (Prepared by the University of Ottawa Evidence-based \nPractice Center under Contract No. HHSA 290-2007-10059-I.) AHRQ Publication No. 12-E004-\nEF. Rockville, MD: Agency for Healthcare Research and Quality. March 2012. \nhttp:\/\/www.ahrq.gov\/clinic\/epcix.htm."},{"issue":"5","key":"3057_CR32","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/emj.15.5.298","volume":"15","author":"S Nadel","year":"1998","unstructured":"Nadel S, Britto J, Booy R, Maconochie I, Habibi P, Levin M. Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med. 1998;15(5):298\u2013303.","journal-title":"J Accid Emerg Med"},{"issue":"6","key":"3057_CR33","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1542\/peds.2010-0479","volume":"126","author":"D Schnadower","year":"2010","unstructured":"Schnadower D, Kuppermann N, Macias CG, Freedman SB, Baskin MN, Ishimine P, et al. Febrile infants with urinary tract infections at very low risk for adverse events and bacteremia. Pediatrics. 2010;126(6):1074\u201383.","journal-title":"Pediatrics."},{"key":"3057_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2019.04.053","volume":"212","author":"J Nugent","year":"2019","unstructured":"Nugent J, Childers M, Singh-Miller N, Howard R, Allard R, Eberly M. Risk of meningitis in infants aged 29 to 90 days with urinary tract infection: a systematic review and Meta-analysis. J Pediatr. 2019;212:102\u2013110.e5 Available from: https:\/\/doi.org\/10.1016\/j.jpeds.2019.04.053.","journal-title":"J Pediatr"},{"issue":"7","key":"3057_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00006454-200007000-00009","volume":"19","author":"O Honkinen","year":"2000","unstructured":"Honkinen O, Jahnukainen T, Mertsola J, Eskola J, Ruuskanen O. Bacteremic urinary tract infection in children. Pediatr Infect Dis J. 2000;19(7):630\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"3057_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/adc.11.64.171","volume":"64","author":"W Craig","year":"1936","unstructured":"Craig W. Meningitis in the newborn. Arch Dis Child. 1936;64:171\u201386.","journal-title":"Arch Dis Child"},{"key":"3057_CR37","unstructured":"Healthcare Cost and Utilization Project [Internet]. U.S. Department of Health and Human Services. 2019. p. https:\/\/hcupnet.ahrq.gov\/. Available from: https:\/\/hcupnet.ahrq.gov\/"},{"key":"3057_CR38","unstructured":"Arias E, Xu JQ. United States life tables, 2017. \nNational Vital Statistics Reports; vol 68 no 7. \nHyattsville: National Center for Health \nStatistics. 2019."},{"key":"3057_CR39","doi-asserted-by":"crossref","unstructured":"Hart RJ, Stevenson MD, Smith MJ, Scott LJA, Cross K. Cost-effectiveness of strategies for offering influenza vaccine in the pediatric emergency department. JAMA Pediatr. 2018;172(1):e173879.","DOI":"10.1001\/jamapediatrics.2017.3879"},{"issue":"1","key":"3057_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2803-0","volume":"17","author":"M Sanchez-Luna","year":"2017","unstructured":"Sanchez-Luna M, Burgos-Pol R, Oyag\u00fcez I, Figueras-Aloy J, S\u00e1nchez-Sol\u00eds M, Martin\u00f3n-Torres F, et al. Cost-utility analysis of Palivizumab for respiratory syncytial virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain. BMC Infect Dis. 2017;17(1):1\u201311.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"3057_CR41","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"G Sanders","year":"2016","unstructured":"Sanders G, Neumann P, Basu A, Brock D, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. J Am Med Assoc. 2016;316(10):1093\u2013103.","journal-title":"J Am Med Assoc"},{"issue":"2 SUPPL","key":"3057_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/0272989X98018002S09","volume":"18","author":"AA Stinnett","year":"1998","unstructured":"Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Mak. 1998;18(2 SUPPL):68\u201380.","journal-title":"Med Decis Mak"},{"key":"3057_CR43","doi-asserted-by":"crossref","unstructured":"Pantell RH, Roberts KB, Adams WG, Dreyer BP, Kuppermann N, O'Leary ST, Okechukwu K, Woods CR Jr; SUBCOMMITTEE ON FEBRILE INFANTS. Evaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old. Pediatrics. 2021;148(2):e2021052228.","DOI":"10.1542\/peds.2021-052228"},{"issue":"6","key":"3057_CR44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/INF.0000000000000225","volume":"33","author":"TL Greenhow","year":"2014","unstructured":"Greenhow TL, Hung Y-Y, Herz A, Losada E, Pantell RH. The changing epidemiology of serious bacterial infections in young infants. Pediatr Infect Dis J. 2014;33(6):595\u2013600.","journal-title":"Pediatr Infect Dis J"},{"key":"3057_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-5-42","volume":"5","author":"LA Prosser","year":"2007","unstructured":"Prosser LA, Corso PS. Measuring health-related quality of life for child maltreatment: a systematic literature review. Health Qual Life Outcomes. 2007;5:1\u201310.","journal-title":"Health Qual Life Outcomes"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-03057-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-03057-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-03057-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T09:05:24Z","timestamp":1643879124000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-03057-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3057"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-03057-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"assertion":[{"value":"12 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval was not required for this study that did not use human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors KAN, SR, NSR, JD, and KJS declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}